-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$163.2946.44% Upside
Recent Analyst Forecasts and Stock Ratings
BioNTech SE Frequently Asked Questions
-
What analysts cover BioNTech SE?
BioNTech SE has been rated by research analysts at Leerink Partners, Goldman Sachs, BMO Capital, Morgan Stanley, Jefferies, Bank of America Securities in the past 90 days.